Structural and Functional Differences Among Human Surfactant Proteins SP-A1, SP-A2 and Co-expressed SP-A1/SP-A2: Role of Supratrimeric Oligomerization

Overview

Journal Biochem J

Specialty Biochemistry

Date 2007 Jun 5

PMID 17542781

Citations 30

Authors

Fernando Sanchez-Barbero

German Rivas

Wolfram Steinhilber

Cristina Casals

Affiliations

Soon will be listed here.

Abstract

SP-A (surfactant protein A) is a membrane-associated SP that helps to maintain the lung in a sterile and non-inflamed state. Unlike SP-As from other mammalian species, human SP-A consists of two functional gene products: SP-A1 and SP-A2. In all the functions examined, recombinant human SP-A1 invariably exhibits lower biological activity than SP-A2. The objective of the present study was to investigate why SP-A2 possesses greater biological activity than SP-A1 and what advantage accrues to having two polypeptide chains instead of one. We analysed structural and functional characteristics of recombinant baculovirus-derived SP-A1, SP-A2 and co-expressed SP-A1/SP-A2 using a wide array of experimental approaches such as analytical ultracentrifugation, DSC (differential scanning calorimetry) and fluorescence. We found that the extent of supratrimeric assembly is much lower in SP-A1 than SP-A2. However, the resistance to proteolysis is greater for SP-A1 than for SP-A2. Co-expressed SP-A1/SP-A2 had greater thermal stability than SP-A1 and SP-A2 and exhibited properties of each protein. On the one hand, SP-A1/SP-A2, like SP-A2, had a higher degree of oligomerization than SP-A1, and consequently had lower K(d) for binding to bacterial Re-LPS (rough lipopolysaccharide), higher self-association in the presence of calcium and greater capability to aggregate Re-LPS and phospholipids than SP-A1. On the other hand, SP-A1/SP-A2, like SP-A1, was more resistant to trypsin degradation than SP-A2. Finally, the importance of the supratrimeric assembly for SP-A immunomodulatory function is discussed.

Citing Articles

The Immune Modulatory Role of Surfactants in Infection.

Li X, Zeng Q, Liu C, Yi X, Luo H, Tong Q J Inflamm Res. 2025; 18:2909-2922.

PMID: 40034686 PMC: 11873027. DOI: 10.2147/JIR.S507526.

Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.

Coya J, Fraile-Agreda V, de Tapia L, Garcia-Fojeda B, Saenz A, Bengoechea J Front Immunol. 2022; 13:927017.

PMID: 36159837 PMC: 9493720. DOI: 10.3389/fimmu.2022.927017.

The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin .

de Tapia L, Garcia-Fojeda B, Kronqvist N, Johansson J, Casals C Front Immunol. 2022; 13:994328.

PMID: 36105805 PMC: 9464622. DOI: 10.3389/fimmu.2022.994328.

Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4.

Garcia-Fojeda B, Minutti C, Montero-Fernandez C, Stamme C, Casals C Front Immunol. 2022; 13:860262.

PMID: 35444643 PMC: 9014242. DOI: 10.3389/fimmu.2022.860262.

Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.

Numata M, Voelker D Biochim Biophys Acta Mol Cell Biol Lipids. 2022; 1867(6):159139.

PMID: 35240310 PMC: 9050941. DOI: 10.1016/j.bbalip.2022.159139.

References

Wang G, Phelps D, Umstead T, Floros J . Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol. 2000; 278(5):L946-54. DOI: 10.1152/ajplung.2000.278.5.L946. View

Tagaram H, Wang G, Umstead T, Mikerov A, Thomas N, Graff G . Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol. 2006; 292(5):L1052-63. DOI: 10.1152/ajplung.00249.2006. View

Levine A, Whitsett J . Pulmonary collectins and innate host defense of the lung. Microbes Infect. 2001; 3(2):161-6. DOI: 10.1016/s1286-4579(00)01363-0. View

Garcia-Verdugo I, Wang G, Floros J, Casals C . Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry. 2002; 41(47):14041-53. DOI: 10.1021/bi026540l. View

Oberley R, Snyder J . Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics. Am J Physiol Lung Cell Mol Physiol. 2002; 284(5):L871-81. DOI: 10.1152/ajplung.00241.2002. View

Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher J . Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003; 111(10):1589-602. PMC: 155045. DOI: 10.1172/JCI16889. View

Garcia-Verdugo I, Sanchez-Barbero F, Bosch F, Steinhilber W, Casals C . Effect of hydroxylation and N187-linked glycosylation on molecular and functional properties of recombinant human surfactant protein A. Biochemistry. 2003; 42(32):9532-42. DOI: 10.1021/bi0347196. View

Head J, Mealy T, McCormack F, Seaton B . Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem. 2003; 278(44):43254-60. DOI: 10.1074/jbc.M305628200. View

Wallis R, Shaw J, Uitdehaag J, Chen C, Torgersen D, Drickamer K . Localization of the serine protease-binding sites in the collagen-like domain of mannose-binding protein: indirect effects of naturally occurring mutations on protease binding and activation. J Biol Chem. 2004; 279(14):14065-73. DOI: 10.1074/jbc.M400171200. View

10.

Wang G, Bates-Kenney S, Tao J, Phelps D, Floros J . Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry. 2004; 43(14):4227-39. DOI: 10.1021/bi036023i. View

11.

Canadas O, Guerrero R, Garcia-Canero R, Orellana G, Menendez M, Casals C . Characterization of liposomal tacrolimus in lung surfactant-like phospholipids and evaluation of its immunosuppressive activity. Biochemistry. 2004; 43(30):9926-38. DOI: 10.1021/bi036227z. View

12.

Voss T, Eistetter H, SCHAFER K, Engel J . Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol. 1988; 201(1):219-27. DOI: 10.1016/0022-2836(88)90448-2. View

13.

Schuck P . Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000; 78(3):1606-19. PMC: 1300758. DOI: 10.1016/S0006-3495(00)76713-0. View

14.

King R, Simon D, Horowitz P . Aspects of secondary and quaternary structure of surfactant protein A from canine lung. Biochim Biophys Acta. 1989; 1001(3):294-301. DOI: 10.1016/0005-2760(89)90114-8. View

15.

Poon P, Schumaker V . Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge. J Biol Chem. 1991; 266(9):5723-7. View

16.

Haas C, Voss T, Engel J . Assembly and disulfide rearrangement of recombinant surfactant protein A in vitro. Eur J Biochem. 1991; 197(3):799-803. DOI: 10.1111/j.1432-1033.1991.tb15974.x. View

17.

Oosting R, van Greevenbroek M, Verhoef J, Van Golde L, Haagsman H . Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol. 1991; 261(2 Pt 1):L77-83. DOI: 10.1152/ajplung.1991.261.2.L77. View

18.

Tischenko V, Ichtchenko A, Andreyev C, Kajava A . Thermodynamic studies of the collagen-like region of human subcomponent C1q. A water-containing structural model. J Mol Biol. 1993; 234(3):654-60. DOI: 10.1006/jmbi.1993.1618. View

19.

Prockop D, Kivirikko K . Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 1995; 64:403-34. DOI: 10.1146/annurev.bi.64.070195.002155. View

20.

Ruano M, Miguel E, Perez-Gil J, Casals C . Comparison of lipid aggregation and self-aggregation activities of pulmonary surfactant-associated protein A. Biochem J. 1996; 313 ( Pt 2):683-9. PMC: 1216961. DOI: 10.1042/bj3130683. View